These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2590613)

  • 21. Plasma levels of lidocaine after intramuscular injection and subsequent infusion in patients with acute myocardial infarction.
    Oltmanns D; Lübben C; Pentz R; Siegers CP
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):582-4. PubMed ID: 7152740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of intramuscular lidocaine in the acute stage of myocardial infarction].
    Djiane P; Egre A; Perchicot B; Bory M; Serradimigni A; Bruguerolle B; Bouyard P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):931-8. PubMed ID: 6793010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of lignocaine on heart rate in patients with sinus bradycardia associated with proven or suspected acute myocardial infarction.
    Rydén L; Cullhed I; Wasir H
    Cardiovasc Res; 1972 Nov; 6(6):664-70. PubMed ID: 4656474
    [No Abstract]   [Full Text] [Related]  

  • 24. Lignocaine therapy after acute myocardial infarction.
    Chopra MP; Portal RW; Aber CP
    Br Med J; 1969 Jan; 1(5638):213-6. PubMed ID: 5762622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison between effectiveness of intramuscular and intravenous lignocaine on ventricular arrhythmia complicating acute myocardial infarction.
    Rydén L; Waldenström A; Ehn L; Holmberg S; Husaini M
    Br Heart J; 1973 Nov; 35(11):1124-31. PubMed ID: 4128310
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma lignocaine concentrations associated with extradural analgesia in patients with and without multiple organ failure.
    Putensen C; Lingnau W; Putensen-Himmer G; Herold M
    Br J Anaesth; 1992 Nov; 69(5):513-6. PubMed ID: 1467084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lignocaine in experimental myocardial infarction: failure to prevent neutrophil accumulation and ventricular fibrillation and to reduce infarct size.
    de Lorgeril M; Rousseau G; Basmadjian A; Latour JG
    Cardiovasc Res; 1988 Jun; 22(6):439-46. PubMed ID: 3224356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lignocaine therapy for ventricular ectopic activity after acute myocardial infarction: a double-blind trial.
    Chopra MP; Thadani U; Portal RW; Aber CP
    Br Med J; 1971 Sep; 3(5776):668-70. PubMed ID: 4936439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. alpha 1-Acid glycoprotein and plasma lidocaine binding.
    Shand DG
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():27-31. PubMed ID: 6705424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lignocaine kinetics in cardiac patients and aged subjects.
    Nation RL; Triggs EJ; Selig M
    Br J Clin Pharmacol; 1977 Aug; 4(4):439-48. PubMed ID: 901735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.
    Routledge PA; Shand DG; Barchowsky A; Wagner G; Stargel WW
    Clin Pharmacol Ther; 1981 Aug; 30(2):154-7. PubMed ID: 7249498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein binding and disposition of lignocaine in the elderly.
    Cusack B; O'Malley K; Lavan J; Noel J; Kelly JG
    Eur J Clin Pharmacol; 1985; 29(3):323-9. PubMed ID: 4076329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring.
    Joel SE; Bryson SM; Small M; Hillis WS; Kelman AW; Whiting B
    Ther Drug Monit; 1983; 5(3):271-7. PubMed ID: 6636255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction.
    Routledge PA; Stargel WW; Wagner GS; Shand DG
    Ann Intern Med; 1980 Nov; 93(5):701-4. PubMed ID: 7212479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ventricular tachyarrhythmias and lignocaine prophylaxis in acute myocardial infarction. A clinical and therapeutic study.
    Mogensen L
    Acta Med Scand Suppl; 1970; 513():1-80. PubMed ID: 5288550
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of lignocaine on plasma protein binding and pharmacokinetics of verapamil in dogs.
    Belpaire FM; De Rick A; Bourda A; De Smet F; Rosseel MT; Bogaert MG
    J Pharm Pharmacol; 1990 Jan; 42(1):45-9. PubMed ID: 1969949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic effects of combined treatment with lignocaine, procainamide and practolol in acute myocardial infarction.
    Nordlander R; Nyquist O
    Cardiology; 1980; 66(1):27-42. PubMed ID: 7388852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of oral cimetidine on total and unbound serum lidocaine concentrations in patients with suspected myocardial infarction.
    Berk SI; Gal P; Bauman JL; Douglas JB; McCue JD; Powell JR
    Int J Cardiol; 1987 Jan; 14(1):91-4. PubMed ID: 3804509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reappraisal of lignocaine therapy in management of myocardial infarction.
    Pentecost BL; De Giovanni JV; Lamb P; Cadigan PJ; Evemy KL; Flint EJ
    Br Heart J; 1981 Jan; 45(1):42-7. PubMed ID: 7459164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodynamic effects of lignocaine in acute myocardial infarction.
    Stannard M; Sloman G; Sangster L
    Br Med J; 1968 May; 2(5603):468-9. PubMed ID: 5648291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.